147 related articles for article (PubMed ID: 1736013)
1. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.
Orfao A; Ciudad J; González M; San Miguel JF; García AR; López-Berges MC; Ramos F; Del Cañizo MC; Ríos A; Sanz M
Leukemia; 1992 Jan; 6(1):47-51. PubMed ID: 1736013
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
3. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
4. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
5. Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization.
Tabernero MD; San Miguel JF; Garcia JL; Garcia-Isidoro M; Wiegant J; Ciudad J; Gonzalez M; Rios A; Raap A; Orfao A
Cytometry; 1995 Sep; 22(3):217-22. PubMed ID: 8556953
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of bone marrow histology in chronic lymphocytic leukemia. A study of 335 untreated cases from a single institution.
Mauro FR; De Rossi G; Burgio VL; Caruso R; Giannarelli D; Monarca B; Romani C; Baroni CD; Mandelli F
Haematologica; 1994; 79(4):334-41. PubMed ID: 7806088
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum albumin in chronic lymphocytic leukemia.
Levis A; Ficara F; Marmont F; De Crescenzo A; Resegotti L
Haematologica; 1991; 76(2):113-9. PubMed ID: 1937168
[TBL] [Abstract][Full Text] [Related]
8. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
Molica S; Tucci L; Levato D; Docimo C
Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
12. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
15. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
16. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
Dhodapkar M; Tefferi A; Su J; Phyliky RL
Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
[TBL] [Abstract][Full Text] [Related]
17. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
18. Multimodal image analysis of chronic leukemic lymphoproliferative disorders and the hypothesis of "single" and "multiple" programmed stops in the development of typical and atypical forms of leukemias and lymphomas.
Kardum-Skelin I; Puskarić BJ; Radić-Kristo D; Jaksić O; Kardum M; Jaksić B
Coll Antropol; 2010 Jun; 34(2):367-76. PubMed ID: 20698104
[TBL] [Abstract][Full Text] [Related]
19. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.
Tadmor T; Shvidel L; Aviv A; Ruchlemer R; Bairey O; Yuklea M; Herishanu Y; Braester A; Rahimi-Levene N; Vernea F; Ben-Ezra J; Bejar J; Polliack A;
Cancer; 2013 May; 119(10):1853-9. PubMed ID: 23423815
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
